MZL

Clinical trials for MZL explained in plain language.

Never miss a new study

Get alerted when new MZL trials appear

Sign up with your email to follow new studies for MZL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2

Two-Drug attack tested for Hard-to-Treat blood cancer

Disease control Recruiting now

This study is testing if a combination of two drugs, rituximab and venetoclax, can effectively treat marginal zone lymphoma (MZL) in people who haven't had chemotherapy before. The goal is to control the cancer and keep it from coming back. About 33 participants will receive the …

Matched conditions: MZL

Phase: PHASE2 • Sponsor: Gottfried von Keudell, MD PhD • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

MZL

Get alerted when new MZL trials appear

Two-Drug attack tested for Hard-to-Treat blood cancer